Integrative biological studies of antitumour agents

Integrative biological studies of antitumour agents

Opis bibliograficzny
Główni autorzy:	Johnson, L, Willis, A, Byrne, H, Laughton, C
Format:	Conference item
Wydane:	2008

Podobne zapisy

An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4.
od: Johnson, L, i wsp.
Wydane: (2011)

A systems biology approach to the analysis of DNA-interactive antitumour agents
od: Laughton, C, i wsp.
Wydane: (2006)

The Chemistry of antitumour agents /
od: Wilman, Derry E. V.
Wydane: (1990)

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
od: Magda A.-A. El-Sayed, i wsp.
Wydane: (2018-01-01)

An approach to the generation of simple analogues of the antitumour agent spicamycin.
od: Mons, S, i wsp.
Wydane: (2003)

Synthesis of quinazolindionyl amino acid and dipeptide derivatives as possible antitumour agents
od: A. Aboelmagd, i wsp.
Wydane: (2019-07-01)

A highly cytotoxic L-rhamnose analogue of the antitumour agent spicamycin
od: Martin, A, i wsp.
Wydane: (1998)

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland
od: D Kyburz, i wsp.
Wydane: (2020-02-01)

Synthesis and biological evaluation of enantiomeric rhamnose analogues of the antitumour agent spicamycin - is the mode of action by modification of N-linked glycoproteins?
od: Martin, A, i wsp.
Wydane: (1999)

Antitumour-promoting and antitumour activities of the crude extract from the leaves of Juniperus chinensis
od: Ali, Abdul Manaf, i wsp.
Wydane: (1996)

Biochemical mechanisms of platinum antitumour drugs /
od: McBrien, D. C. H., i wsp.
Wydane: (1986)

On the antitumour effects of B vitamins
od: O. A. Gromova, i wsp.
Wydane: (2024-02-01)

An Overview of Antitumour Activity of Polysaccharides
od: Hongzhen Jin, i wsp.
Wydane: (2022-11-01)

TIN-BASED ANTITUMOUR DRUGS
od: Gielen, Marcel
Wydane: (1994-05-01)

Novel disulfides with antitumour efficacy and specificity
od: Griffiths, R, i wsp.
Wydane: (2005)

Antitumour principles from alpinia galanga /
od: Hideji Itokawa

Antitumour Effects of Astaxanthin and Adonixanthin on Glioblastoma
od: Shohei Tsuji, i wsp.
Wydane: (2020-09-01)

R(h)oad to antitumour therapy
od: Viviane Nascimento Da Conceicao, i wsp.
Wydane: (2022-12-01)

Adsorption of Some Antitumour Compounds on Polymer Adsorbents
od: M.O. Kovbuz, i wsp.
Wydane: (1996-08-01)

Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
od: Liu J, i wsp.
Wydane: (2020-01-01)

Semisynthesis of Andrographolide Derivatives and Evaluation of Their Antitumour Properties
od: Rao, Jada Srinivasa
Wydane: (2004)

The Antitumour Mechanisms of Carotenoids: A Comprehensive Review
od: Andrés Baeza-Morales, i wsp.
Wydane: (2024-08-01)

Synthesis and antitumour activity of varitriol and its analogues
od: Oľga Caletková, i wsp.
Wydane: (2012-05-01)

Recent Advances in Functional Carbon Quantum Dots for Antitumour
od: Cai R, i wsp.
Wydane: (2021-10-01)

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
od: Katrin Kramer, i wsp.
Wydane: (2019-01-01)

Antitumour Activity of Dehydroxymethylepoxyquinomycin (DHMEQ): a Literature Review
od: K. Umezawa, i wsp.
Wydane: (2021-04-01)

A single‐domain small protein Med‐ORF10 regulates the production of antitumour agent medermycin in Streptomyces
od: Xiaofeng Cai, i wsp.
Wydane: (2021-09-01)

Impact of oncogenic pathways on evasion of antitumour immune responses
od: Spranger, Stefani
Wydane: (2020)

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma
od: Rahel Mascha Stammer, i wsp.
Wydane: (2017-01-01)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
od: Emily J. Kay, i wsp.
Wydane: (2023-04-01)

Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics
od: Piao Zhou, i wsp.
Wydane: (2021-01-01)

Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment
od: Moises A. Franco-Molina, i wsp.
Wydane: (2018-07-01)

Evaluation of the purified fraction of Wilbrandia (c. f. ) verticillata for antitumour activity
od: V. S. N. Rao, i wsp.
Wydane: (1991-01-01)

Phenolic profile, antibacterial, antimutagenic and antitumour evaluation of Veronica urticifolia Jacq.
od: Jelena Živković, i wsp.
Wydane: (2014-07-01)

Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.
od: Fens, M, i wsp.
Wydane: (2008)

Boosting antitumour immunity through targeted delivery of interferon-α
od: Fairchild, P, i wsp.
Wydane: (2019)

Advances in antitumour therapy with oncolytic herpes simplex virus combinations
od: Xuejiao Qi
Wydane: (2024-07-01)

Learning the Lessons of Antitumour Necrosis Factor Therapy-Associated Psoriasis
od: Matt Shale, i wsp.
Wydane: (2009-01-01)

Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity
od: Shlomo Ben-Efraim
Wydane: (1992-01-01)

Design, synthesis and antitumour activity evaluation of novel dolutegravir derivatives
od: Xi-Xi Hou, i wsp.
Wydane: (2023-08-01)